Radiation therapy plays a central role in the treatment of head and neck (H&N) cancer patients worldwide. Conventional H&N radiation is routinely associated with acute and long-term toxicities which derive from the spectrum of normal tissues encompassed within the radiation design. Although intensified radiation fractionation and concurrent radiochemotherapy programs provide increasing promise for enhanced tumor control rates, these methods are generally accompanied by an increase in normal tissue toxicity. Efforts to diminish the routine toxicities associated with H&N radiotherapy offer potential to improve patient quality of life without compromise in tumor control. The overall objective of this project is to examine the capacity of tomotherapy to conformally avoid selected normal structures in the treatment of H&N cancer patients. We hypothesize that conformal avoidance tomotherapy will allow comprehensive H&N radiation coverage of the primary tumor and regional lymphatics with significant sparing of dose to specified normal tissue structures. Whereas critical normal tissues can be precisely delineated on imaging studies, the tissues t risk for potential tumor invasion or occult regional nodal spread are considerably less certain. Step 1 in this project will involve precise characterization and quantitative analysis of normal tissues damage to parotid glands and auditory apparatus in H&N cancer patients undergoing conventional shrinking-field H&N radiotherapy. Experimental generation of tomotherapy treatment plans in patients undergoing conventional H&N radiotherapy will be performed so as to gain expertise in common patterns of tomotherapy field design for complex H&N cancer patients. Step 2 will involve the treatment of a pilot cohort of H&N cancer patients with helical tomotherapy, incorporating analysis of daily treatment setup using the infrared radiocamera using to precisely monitor and adjust for variations in day-to-day patient positioning. Step 3 will involve delivery of conformal avoidance tomotherapy to H&N cancer patients within the context of a Phase II clinical trial. Setup verification analysis will be extended in Step 3 and the process of treatment delivery modification will be examined. Physiological testing (salivary and auditory) as well as patient-driven quality of life analysis will be performed for all patients. The precision characteristics of conformal avoidance tomotherapy are uniquely suited to accomplish selective normal tissue sparing in H&N cancer patients. This effort is anticipated to enhance overall health status and quality of life in H&N cancer patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA088960-02
Application #
6651752
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Brower, Jeffrey V; Forman, Jeffrey D; Kupelian, Patrick A et al. (2016) Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer. Radiother Oncol 118:99-104
Cannon, Donald M; Mehta, Minesh P; Adkison, Jarrod B et al. (2013) Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer. J Clin Oncol 31:4343-8
Hong, Theodore S; Tome, Wolfgang A; Harari, Paul M (2012) Heterogeneity in head and neck IMRT target design and clinical practice. Radiother Oncol 103:92-8
Chi, Alexander; Tomé, Wolfgang A; Fowler, Jack et al. (2011) Stereotactic body radiation therapy in non-small-cell lung cancer: linking radiobiological modeling and clinical outcome. Am J Clin Oncol 34:432-41
Gondi, Vinai; Tome, Wolfgang A; Marsh, James et al. (2010) Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol 95:327-31
Harari, Paul M; Song, Shiyu; Tomé, Wolfgang A (2010) Emphasizing conformal avoidance versus target definition for IMRT planning in head-and-neck cancer. Int J Radiat Oncol Biol Phys 77:950-8
Deveau, Michael A; Gutiérrez, Alonso N; Mackie, Thomas R et al. (2010) Dosimetric impact of daily setup variations during treatment of canine nasal tumors using intensity-modulated radiation therapy. Vet Radiol Ultrasound 51:90-6
Lawrence, Jessica A; Forrest, Lisa J; Turek, Michelle M et al. (2010) Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy. Vet Radiol Ultrasound 51:561-70
Ritter, Mark; Forman, Jeffrey; Kupelian, Patrick et al. (2009) Hypofractionation for prostate cancer. Cancer J 15:1-6
Schubert, Leah K; Westerly, David C; Tomé, Wolfgang A et al. (2009) A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3,800 helical tomotherapy treatments. Int J Radiat Oncol Biol Phys 73:1260-9

Showing the most recent 10 out of 50 publications